<PAGE>
FORM 8-A
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Biotech HOLDRs/SM/ Trust
(Exact name of registrant as specified in its charter)
New York not applicable
(State of incorporation or organization) (I.R.S. Employer
Identification No.)
c/o The Bank of New York, as Trustee
101 Barclay Street, 22-W
New York, New York 10286
(Address of principal executive offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class Name of each exchange on which
to be so registered: each class is to be registered:
Biotech HOLDRs American Stock Exchange
If this form relates to the registration of a class of securities pursuant
to Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A.(c), check the following box. [x]
If this form relates to the registration of a class of securities pursuant
to Section 12(g) of the Exchange Act and is effective pursuant to General
Instruction A.(d), check the following box. [ ]
Securities Act registration file number to which this form relates:
333-89355
Securities to be registered pursuant to Section 12(g) of the Act:
None
<PAGE>
2
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1. Description of Registrant's Securities to be Registered.
The description of the 1,000,000,000 Depositary Receipts to be issued by
the Biotech HOLDRs Trust (the "Biotech HOLDRs") to be registered hereunder is
set forth under the caption entitled "Description of Biotech HOLDRs" in the
prospectus dated November 22, 1999, which description is hereby incorporated by
reference. The prospectus was filed with the Securities and Exchange Commission
pursuant to Rule 424(b)(2) of the Securities Act of 1933 on November 23, 1999.
Item 2. Exhibits.
1. Form of Depositary Trust Agreement is set forth in Exhibit 4.1 to the
registrant's Registration Statement on Form S-1 (Registration No.
333-89355) (the "Registration Statement") and is incorporated herein by
reference.
2. Form of Biotech HOLDRs is set forth in Exhibit 4.1 to the Registration
Statement and is incorporated herein by reference.
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereto duly authorized.
MERRILL LYNCH, PIERCE, FENNER & SMITH
INCORPORATED, as Initial Depositor,
on behalf of
Biotech HOLDRS Trust
Date: November 23, 1999 By: /s/ STEPHEN G. BODURTHA
----------------------------
Name: Stephen G. Bodurtha
Title: Attorney-in-Fact
